Published in Ann Neurol on August 22, 2011
AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One (2012) 2.67
Key roles of adjuvants in modern vaccines. Nat Med (2013) 2.62
Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One (2012) 2.23
ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet (2013) 1.55
Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol (2014) 1.48
Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet (2012) 1.48
A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics (2012) 1.25
Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol (2012) 1.09
Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet (2013) 1.08
The autoimmune basis of narcolepsy. Curr Opin Neurobiol (2013) 1.03
Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk. PLoS One (2014) 1.02
Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. Sleep (2014) 1.00
Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun (2013) 0.99
Hypocretin deficiency develops during onset of human narcolepsy with cataplexy. Sleep (2013) 0.98
No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. PLoS One (2013) 0.96
Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci U S A (2014) 0.94
High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep (2013) 0.92
Narcolepsy: clinical differences and association with other sleep disorders in different age groups. J Neurol (2012) 0.91
HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet (2015) 0.91
Monozygotic twins concordant for Kleine-Levin syndrome. BMC Neurol (2012) 0.90
H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. Proc Natl Acad Sci U S A (2015) 0.89
Functional magnetic resonance imaging in narcolepsy and the kleine-levin syndrome. Front Neurol (2014) 0.87
HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep (2014) 0.87
Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain (2013) 0.87
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults. Infect Chemother (2013) 0.87
Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One (2014) 0.86
Heterologous prime-boost vaccination using an AS03B-adjuvanted influenza A(H5N1) vaccine in infants and children<3 years of age. J Infect Dis (2014) 0.84
History of narcolepsy at Stanford University. Immunol Res (2014) 0.83
Vaccination of healthcare workers: A review. Hum Vaccin Immunother (2015) 0.83
AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial. J Infect Dis (2014) 0.82
Pandemrix™ and narcolepsy: A critical appraisal of the observational studies. Hum Vaccin Immunother (2015) 0.81
Recent publications in medical microbiology and immunology: a retrospective. Med Microbiol Immunol (2011) 0.81
Etiopathogenesis and neurobiology of narcolepsy: a review. J Clin Diagn Res (2013) 0.81
Narcolepsy and A(H1N1)pdm09 vaccination: shaping the research on the observed signal. Hum Vaccin Immunother (2013) 0.81
Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol (2015) 0.79
Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol (2016) 0.79
Narcolepsy and influenza vaccination-the inappropriate awakening of immunity. Ann Transl Med (2016) 0.79
Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset. Brain Behav Immun (2015) 0.79
Immune camouflage: relevance to vaccines and human immunology. Hum Vaccin Immunother (2014) 0.79
Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia. Chest (2015) 0.78
Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study. J Clin Sleep Med (2017) 0.78
Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination. Influenza Other Respir Viruses (2015) 0.78
Sleep physiology, abnormal States, and therapeutic interventions. Ochsner J (2012) 0.78
Narcolepsy-cataplexy: is streptococcal infection a trigger? J Clin Sleep Med (2013) 0.78
Incidence of Narcolepsy in Germany. Sleep (2015) 0.78
Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nat Sci Sleep (2015) 0.78
Allergies and Disease Severity in Childhood Narcolepsy: Preliminary Findings. Sleep (2015) 0.77
Prevention of influenza in healthy children. Expert Rev Anti Infect Ther (2012) 0.77
Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™and Narcolepsy. PLoS One (2016) 0.76
Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies. Hum Vaccin Immunother (2015) 0.76
H1N1 infection of sleep/wake regions results in narcolepsy-like symptoms. Proc Natl Acad Sci U S A (2016) 0.75
Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells. PLoS One (2017) 0.75
No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination. PLoS One (2016) 0.75
Narcolepsy Following Yellow Fever Vaccination: A Case Report. Front Neurol (2016) 0.75
Infancy narcolepsy: Streptococcus infection as a causal factor. Sleep Sci (2015) 0.75
Shining evolutionary light on human sleep and sleep disorders. Evol Med Public Health (2016) 0.75
Microenvironmental Gene Expression Plasticity Among Individual Drosophila melanogaster. G3 (Bethesda) (2016) 0.75
Post Tick-Borne Encephalitis Virus Vaccination Narcolepsy with Cataplexy. Sleep (2016) 0.75
Cases of Narcolepsy-Cataplexy Syndrome Following H1N1 Vaccination. Noro Psikiyatr Ars (2014) 0.75
Sleep: narcolepsy associated with the 2009 H1N1 pandemic in China. Nat Rev Neurol (2011) 0.75
Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study. J Clin Med Res (2016) 0.75
Improving predictive accuracy of a survey measure of risk for narcolepsy. Health Psychol Behav Med (2014) 0.75
Circadian Rest-Activity Rhythm in Pediatric Type 1 Narcolepsy. Sleep (2016) 0.75
Safety assessment of adjuvanted vaccines: Methodological considerations. Hum Vaccin Immunother (2015) 0.75
Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010. PLoS One (2016) 0.75
Waking up to narcolepsy. Ann Neurol (2011) 0.75
Temporal Association of Certain Neuropsychiatric Disorders Following Vaccination of Children and Adolescents: A Pilot Case-Control Study. Front Psychiatry (2017) 0.75
Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats. Hum Vaccin Immunother (2016) 0.75
Altered Sleep Stage Transitions of REM Sleep: A Novel and Stable Biomarker of Narcolepsy. J Clin Sleep Med (2015) 0.75
Genome sequencing in microfabricated high-density picolitre reactors. Nature (2005) 150.21
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90
DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 14.07
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med (2004) 11.17
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol (2009) 9.67
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66
Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med (2012) 8.68
Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell (2011) 7.30
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 5.77
Global diversity in the human salivary microbiome. Genome Res (2009) 5.16
Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol (2008) 5.12
Narcolepsy with cataplexy. Lancet (2007) 4.81
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res (2011) 4.55
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell (2006) 4.53
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet (2006) 4.35
History of the development of sleep medicine in the United States. J Clin Sleep Med (2005) 4.22
IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest (2008) 4.12
Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01
Edgetic perturbation models of human inherited disorders. Mol Syst Biol (2009) 3.96
Exchange-coupled nanocomposite magnets by nanoparticle self-assembly. Nature (2002) 3.71
The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature (2007) 3.55
Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood (2011) 3.41
Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet (2009) 3.33
CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell (2011) 3.31
Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet (2008) 3.24
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19
Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science (2013) 3.17
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet (2010) 3.15
Post-H1N1 narcolepsy-cataplexy. Sleep (2010) 3.10
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A (2006) 3.09
The scoring of respiratory events in sleep: reliability and validity. J Clin Sleep Med (2007) 3.07
Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep (2009) 3.06
Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol (2008) 3.03
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature (2013) 3.00
Upper-airway stimulation for obstructive sleep apnea. N Engl J Med (2014) 2.98
Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol (2012) 2.83
Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol (2006) 2.76
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet (2003) 2.71
Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am J Hum Genet (2008) 2.65
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer (2011) 2.56
Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J Infect Dis (2012) 2.53
Retracted CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Transl Med (2013) 2.51
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A (2003) 2.50
MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. Genome Res (2010) 2.44
N-Benzyl-2-(2,6-dichloro-phen-oxy)-acetamide. Acta Crystallogr Sect E Struct Rep Online (2008) 2.36
Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain (2006) 2.35
Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol (2007) 2.34
Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol (2006) 2.32
Control of the pattern-recognition receptor EFR by an ER protein complex in plant immunity. EMBO J (2009) 2.28
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet (2005) 2.28
The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci (2002) 2.28
Genetics of sleep and sleep disorders. Cell (2011) 2.26
Histone demethylase UTX-1 regulates C. elegans life span by targeting the insulin/IGF-1 signaling pathway. Cell Metab (2011) 2.22
Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci U S A (2007) 2.20
Project management system for structural and functional proteomics: Sesame. J Struct Funct Genomics (2003) 2.19
An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems. The optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med (2013) 2.19
New bioinformatics resources for metabolomics. Pac Symp Biocomput (2007) 2.19
Regulation of human airway epithelial cell IL-8 expression by MAP kinases. Am J Physiol Lung Cell Mol Physiol (2002) 2.19
Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath (2002) 2.17
Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem (2002) 2.17
Effects of vacuum-assisted closure on wound microcirculation: an experimental study. Asian J Surg (2005) 2.14
Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet (2009) 2.14
The effects of sleep loss and fatigue on resident-physicians: a multi-institutional, mixed-method study. Acad Med (2004) 2.13
A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. Circ Res (2006) 2.12
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell (2012) 2.11
Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet (2008) 2.09
Generation of functional ion-channel tools by E3 targeting. Nat Biotechnol (2005) 2.08
The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res (2009) 2.08
Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica (2007) 2.07
Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart disease. Environ Health Perspect (2012) 2.05
Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimation. Neuroimage (2010) 2.04
A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. J Biol Chem (2005) 2.03
Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem (2003) 2.01
Expression of midkine and endoglin in breast carcinomas with different immunohistochemical profiles. APMIS (2010) 2.00
Sleep apnea in acute coronary syndrome: high prevalence but low impact on 6-month outcome. Sleep Med (2006) 2.00
Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR). Cardiovasc Res (2005) 1.99
Effect of otitis media with effusion and its clinical intervention on the development of mastoid in children. Acta Otolaryngol (2014) 1.98
TRPC channel activation by extracellular thioredoxin. Nature (2008) 1.97
Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem (2005) 1.95
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proc Natl Acad Sci U S A (2009) 1.94
Prevalence of symptoms and risk of sleep apnea in primary care. Chest (2003) 1.93
Thermal difference spectra: a specific signature for nucleic acid structures. Nucleic Acids Res (2005) 1.91
Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. Sleep (2007) 1.88